Table 2 OAC use in different years
| Â | Standard Dose | Underdosing | Overdosing | Use at low risk of stroke | P-value |
|---|---|---|---|---|---|
OAC | |||||
 2013 | 12(8.2%) | 101(68.7%) | 3(2.0%) | 31(21.1%) | 0.000 |
 2018 | 138(20.4%) | 408(60.4%) | 13(1.9%) | 116(17.2%) | |
 2023 | 310(40.1%) | 321(41.5%) | 35(4.5%) | 108(14.0%) | |
| Â | 460(28.8%) | 830(52.0%) | 51(3.2%) | 255(16.0%) | |
Warfarin | |||||
 2013 | 12(8.2%) | 101(68.7%) | 3(2.0%) | 31(21.1%) | 0.006 |
 2018 | 55(19.6%) | 185(65.8%) | 5(1.8%) | 36(12.8%) | |
| Â | 67(15.7%) | 286(66.8%) | 8(1.9%) | 67(15.7%) | Â |
NOAC | |||||
 2018 | 83(21.1%) | 223(56.6%) | 8(2%) | 80(20.3%) | 0.000 |
 2023 | 310(40.1%) | 321(41.5%) | 35(4.5%) | 108(14.0%) | |
| Â | 393(33.6%) | 544(46.6%) | 43(3.7%) | 188(16.1%) | Â |